FDA Looks For More Women In Medtech Trials
Based on the results of a newly unveiled study, the FDA plans to implement new processes to ensure that women make up an appropriate portion of medical device post-approval studies. Nearly half of the premarket approvals and humanitarian device exemptions handed out since 1991 have included post-approval approval requirements, and sex-based data is available for more than 90% of them, according to the study authors. The reports show that women frequently make up less than half of the patients population in cardiovascular, orthopedic, and renal/urologic studies.
Help employers find you! Check out all the jobs and post your resume.